Lovesac, Avidity Biosciences, Veritone, and Other Major Stocks Decline in Thursday's Pre-Market Trading
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 11 2025
0mins
Source: Benzinga
U.S. Stock Futures: U.S. stock futures are up, with Dow futures increasing by approximately 0.2% on Thursday morning.
Lovesac Co Performance: Lovesac Co's shares fell 13% in pre-market trading after reporting a second-quarter loss of 45 cents per share, which was better than expected, but the company lowered its FY2026 EPS guidance significantly.
Other Stocks Declining: Several other stocks also saw significant declines in pre-market trading, including Avidity Biosciences (down 20.1%) and Veritone, Inc. (down 18.7%), following announcements of stock offerings.
Market Overview: The overall market sentiment appears cautious, with multiple companies experiencing sharp declines in their stock prices amid earnings reports and new offerings.
Analyst Views on VERI
Wall Street analysts forecast VERI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VERI is 8.33 USD with a low forecast of 6.00 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
2 Buy
1 Hold
0 Sell
Moderate Buy
Current: 3.870
Low
6.00
Averages
8.33
High
10.00
Current: 3.870
Low
6.00
Averages
8.33
High
10.00
About VERI
Veritone, Inc. builds human-centered enterprise artificial intelligence (AI) solutions. Its AI operating system, aiWARE, uses machine learning algorithms, or AI models, together with a suite of applications, to reveal valuable insights from vast amounts of structured and unstructured data. Highly modular and customizable, aiWARE enables expansive scale with the flexibility to deploy in the cloud, at the edge or in hybrid environments. Its aiWARE platform offers capabilities that are designed to mimic human cognitive functions such as perception, prediction and problem solving, enabling users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. Its aiWARE platform encompasses industry applications, automate studio and developer APIs, intelligent data lake, applications and cognitive analytics, and generative AI. It serves customers in the media, entertainment, public sector and talent acquisition industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
